FGFR3 mutations are frequent in benign skin tumours [43] and have been reported at low frequency in cervical carcinoma [25] and multiple myeloma [44], but are absent in other solid cancers [45, 46], suggesting a tissue-specific role. This evidence concerns the gene FGFR3 and AL amyloidosis.